Chinese pharmaceutical M&A deal value from strategic buyers 2016-2019, by region
Investment in the health and pharmaceutical industry has seen a robust growth in China in the recent five years. Both domestic and foreign investors were actively engaged with merger and acquisition activities. In 2019, there were 228 publicly disclosed investment deals conducted by strategic buyers in the Chinese pharmaceutical sector, with a total value amounting to over 12.5 billion U.S. dollars.